Trade Summary

6 days ago, RA CAPITAL MANAGEMENT, L.P., serving as Dir at Parabilis Medicines, Inc. (PBLS), purchased 244,593 shares at $28.29 per share, for a total transaction value of $6,919,551.27. Following this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 26,529,686 shares of PBLS.

This purchase represents a 0.93% increase in RA CAPITAL MANAGEMENT, L.P.'s stake in the company.

The trade was executed on Monday, July 20, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 22, 2026 at 4:55 PM ET, 2 days after the trade was made.

Parabilis Medicines, Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.